We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 Dec 2020 - 08 Dec 2020
Virtual Venue

Newborns Getting Preoperative Blood Transfusions Have More Complications

By LabMedica International staff writers
Posted on 05 Nov 2020
Print article
Image: A newborn baby’s foot with a peripheral intravenous catheter in the neonatal intensive care unit. Newborns undergoing surgery suffered worse outcomes if they had received preoperative blood transfusion (Photo courtesy of Atichayo).
Image: A newborn baby’s foot with a peripheral intravenous catheter in the neonatal intensive care unit. Newborns undergoing surgery suffered worse outcomes if they had received preoperative blood transfusion (Photo courtesy of Atichayo).
Blood transfusions in the neonatal patient population are common, but there are no established guidelines regarding transfusion thresholds. Little is known about postoperative outcomes in neonates who receive preoperative blood transfusions (PBTs).

Transfusion practices in neonatal intensive care units (ICUs) remain highly variable despite several randomized trials showing no harm with a restrictive transfusion strategy in babies compared with a liberal one. It's not uncommon for anemic newborns to receive transfusions prior to surgery as a precaution.

Medical scientists at the Alfred I. duPont Hospital for Children (Wilmington, DE, USA) and their colleagues identified a total of 12,184 neonates, of whom 1,209 (9.9%) received a PBT, all neonates who underwent surgery. Mortality and composite morbidity (defined as any postoperative complication) in neonates who received a PBT within 48 hours of surgery were compared with that in neonates who did not receive a transfusion.

The team reported that the incidence of 30-day mortality (16.8% versus 2.6%) and morbidity (46.2% versus 16.2%) put neonates who received blood transfusion within 48 hours of surgery at a disadvantage compared with peers not getting transfusion. Blood transfusion remained associated with worse postoperative outcomes after multivariable adjustment and propensity-score matching.

Specific postoperative complications that occurred more frequently in the transfusion group included infection, bleeding requiring transfusion, reintubation, reoperation, and hospital stay beyond 30 days. However, babies who did not receive transfusion had more readmissions within 30 days of surgery. There appeared to be a stronger relationship between mortality and morbidity and blood transfusion with rising preoperative hematocrit (up to 35%), though this finding did not reach statistical significance for interaction.

The authors concluded that it is likely that there is a tipping point or range in which the risks associated with anemia outweigh the risks associated with blood transfusion. For infants with significant anemia, it is plausible that the benefits of a blood transfusion, such as increased oxygen delivery, outweigh the associated risks (i.e., transfusion-related immunomodulation and a proinflammatory state), but as the anemia becomes less severe, the harm of a blood transfusion begins to outweigh the benefit. The study was published on October 1, 2020 in the journal Pediatrics.

Related Links:
Alfred I. duPont Hospital for Children


Print article

Channels

Copyright © 2000-2020 Globetech Media. All rights reserved.